FDA meeting on September 20-21, 2016

Posted in Latest News on September 23, 2016.

pharmacy-pic2

On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of the FDA and the states. The meeting provided an opportunity to discuss each state’s regulatory framework, recent FDA guidance documents, changes to the FDA’s inspection procedures, and information sharing challenges and opportunities.



More Latest News

Pharmacists May Order and Administer COVID-19 Tests
April 24, 2020

Emergency Order 20-006 allows a licensed pharmacist to order and administer FDA approved COVID-19 tests Continue reading


New Legislation Impacting Your Profession
April 15, 2020

Click here to view a full list of bill summaries from the 2020 Florida Legislative Session that may impact your profession. Continue reading